Skip to main content
Erschienen in: European Journal of Nutrition 6/2010

01.09.2010 | Original Contribution

Bilberry juice modulates plasma concentration of NF-κB related inflammatory markers in subjects at increased risk of CVD

verfasst von: Anette Karlsen, Ingvild Paur, Siv K. Bøhn, Amrit K. Sakhi, Grethe I. Borge, Mauro Serafini, Iris Erlund, Petter Laake, Serena Tonstad, Rune Blomhoff

Erschienen in: European Journal of Nutrition | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bilberries are abundant in polyphenols. Dietary polyphenols have been associated with strategies for prevention and treatment of chronic inflammatory diseases. We investigated the effect of bilberry juice on serum and plasma biomarkers of inflammation and antioxidant status in subjects with elevated levels of at least one risk factor for cardiovascular disease (CVD).

Methods

In a randomized controlled trial, participants consumed either bilberry juice (n = 31) or water (n = 31) for 4 weeks.

Results

Supplementation with bilberry juice resulted in significant decreases in plasma concentrations of C-reactive protein (CRP), interleukin (IL)-6, IL-15, and monokine induced by INF-γ (MIG). Unexpectedly, an increase in the plasma concentration of tumor nuclear factor-α (TNF-α) was observed in the bilberry group. CRP, IL-6, IL15, MIG, and TNF-α are all target genes of nuclear factor- kappa B (NF-κB), —a transcription factor that is crucial in orchestrating inflammatory responses. Plasma quercetin and p-coumaric acid increased in the bilberry group, otherwise no differences were observed for clinical parameters, oxidative stress or antioxidant status. Furthermore, we studied the effect of polyphenols from bilberries on lipopolysaccharide (LPS)-induced NF-κB activation in a monocytic cell line. We observed that quercetin, epicatechin, and resveratrol inhibited NF-κB activation.

Conclusions

These findings suggest that supplementation with bilberry polyphenols may modulate the inflammation processes. Further testing of bilberry supplementation as a potential strategy in prevention and treatment of chronic inflammatory diseases is warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867CrossRef Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867CrossRef
2.
Zurück zum Zitat Vakkila J, Lotze MT (2004) Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4:641–648CrossRef Vakkila J, Lotze MT (2004) Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4:641–648CrossRef
3.
Zurück zum Zitat Gilmore TD, Herscovitch M (2006) Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25:6887–6899CrossRef Gilmore TD, Herscovitch M (2006) Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25:6887–6899CrossRef
4.
Zurück zum Zitat Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853–6866CrossRef Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853–6866CrossRef
5.
Zurück zum Zitat Christman JW, Sadikot RT, Blackwell TS (2000) The role of nuclear factor-kappa B in pulmonary diseases. Chest 117:1482–1487CrossRef Christman JW, Sadikot RT, Blackwell TS (2000) The role of nuclear factor-kappa B in pulmonary diseases. Chest 117:1482–1487CrossRef
6.
Zurück zum Zitat Feldmann M, Andreakos E, Smith C, Bondeson J, Yoshimura S, Kiriakidis S, Monaco C, Gasparini C, Sacre S, Lundberg A, Paleolog E, Horwood NJ, Brennan FM, Foxwell BM (2002) Is NF-kappaB a useful therapeutic target in rheumatoid arthritis? Ann Rheum Dis 61(Suppl 2):ii13–ii18 Feldmann M, Andreakos E, Smith C, Bondeson J, Yoshimura S, Kiriakidis S, Monaco C, Gasparini C, Sacre S, Lundberg A, Paleolog E, Horwood NJ, Brennan FM, Foxwell BM (2002) Is NF-kappaB a useful therapeutic target in rheumatoid arthritis? Ann Rheum Dis 61(Suppl 2):ii13–ii18
7.
Zurück zum Zitat Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310CrossRef Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310CrossRef
8.
Zurück zum Zitat Mattson MP, Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107:247–254CrossRef Mattson MP, Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107:247–254CrossRef
9.
Zurück zum Zitat Neurath MF, Becker C, Barbulescu K (1998) Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43:856–860CrossRef Neurath MF, Becker C, Barbulescu K (1998) Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43:856–860CrossRef
10.
Zurück zum Zitat Valen G, Yan ZQ, Hansson GK (2001) Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307–314CrossRef Valen G, Yan ZQ, Hansson GK (2001) Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307–314CrossRef
11.
Zurück zum Zitat Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242 Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242
12.
Zurück zum Zitat Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772 Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772
13.
Zurück zum Zitat Armani A, Becker RC (2005) The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part I. Am Heart J 149:971–976CrossRef Armani A, Becker RC (2005) The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part I. Am Heart J 149:971–976CrossRef
14.
Zurück zum Zitat Blondeau N, Widmann C, Lazdunski M, Heurteaux C (2001) Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 21:4668–4677 Blondeau N, Widmann C, Lazdunski M, Heurteaux C (2001) Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 21:4668–4677
15.
Zurück zum Zitat Valen G (2004) Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure. Basic Res Cardiol 99:1–7CrossRef Valen G (2004) Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure. Basic Res Cardiol 99:1–7CrossRef
16.
Zurück zum Zitat Zhang J, Ping P, Vondriska TM, Tang XL, Wang GW, Cardwell EM, Bolli R (2003) Cardioprotection involves activation of NF-kappa B via PKC-dependent tyrosine and serine phosphorylation of I kappa B-alpha. Am J Physiol Heart Circ Physiol 285:H1753–H1758 Zhang J, Ping P, Vondriska TM, Tang XL, Wang GW, Cardwell EM, Bolli R (2003) Cardioprotection involves activation of NF-kappa B via PKC-dependent tyrosine and serine phosphorylation of I kappa B-alpha. Am J Physiol Heart Circ Physiol 285:H1753–H1758
17.
Zurück zum Zitat Nyman NA, Kumpulainen JT (2001) Determination of anthocyanidins in berries and red wine by high-performance liquid chromatography. J Agric Food Chem 49:4183–4187CrossRef Nyman NA, Kumpulainen JT (2001) Determination of anthocyanidins in berries and red wine by high-performance liquid chromatography. J Agric Food Chem 49:4183–4187CrossRef
18.
Zurück zum Zitat Kalt W, McDonald J, Donner H (2000) Anthocyanins, phenolics and antioxidant capacity of processed lowbush blueberry products. J Food Sci 65:390–393CrossRef Kalt W, McDonald J, Donner H (2000) Anthocyanins, phenolics and antioxidant capacity of processed lowbush blueberry products. J Food Sci 65:390–393CrossRef
19.
Zurück zum Zitat Maatta-Riihinen KR, Kamal-Eldin A, Mattila PH, Gonzalez-Paramas AM, Torronen AR (2004) Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 52:4477–4486CrossRef Maatta-Riihinen KR, Kamal-Eldin A, Mattila PH, Gonzalez-Paramas AM, Torronen AR (2004) Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 52:4477–4486CrossRef
20.
Zurück zum Zitat Ehala S, Vaher M, Kaljurand M (2005) Characterization of phenolic profiles of Northern European berries by capillary electrophoresis and determination of their antioxidant activity. J Agric Food Chem 53:6484–6490CrossRef Ehala S, Vaher M, Kaljurand M (2005) Characterization of phenolic profiles of Northern European berries by capillary electrophoresis and determination of their antioxidant activity. J Agric Food Chem 53:6484–6490CrossRef
21.
Zurück zum Zitat Hakkinen SH, Karenlampi SO, Heinonen IM, Mykkanen HM, Torronen AR (1999) Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem 47:2274–2279CrossRef Hakkinen SH, Karenlampi SO, Heinonen IM, Mykkanen HM, Torronen AR (1999) Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem 47:2274–2279CrossRef
22.
Zurück zum Zitat Zadernowski R, Naczk M, Nesterowicz J (2005) Phenolic acid profiles in some small berries. J Agric Food Chem 53:2118–2124CrossRef Zadernowski R, Naczk M, Nesterowicz J (2005) Phenolic acid profiles in some small berries. J Agric Food Chem 53:2118–2124CrossRef
23.
Zurück zum Zitat Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J, van Breemen RB (2003) Resveratrol in raw and baked blueberries and bilberries. J Agric Food Chem 51:5867–5870CrossRef Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J, van Breemen RB (2003) Resveratrol in raw and baked blueberries and bilberries. J Agric Food Chem 51:5867–5870CrossRef
24.
Zurück zum Zitat Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR (2004) Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 52:4713–4719CrossRef Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR (2004) Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 52:4713–4719CrossRef
25.
Zurück zum Zitat Maatta-Riihinen KR, Kahkonen MP, Torronen AR, Heinonen IM (2005) Catechins and procyanidins in berries of vaccinium species and their antioxidant activity. J Agric Food Chem 53:8485–8491CrossRef Maatta-Riihinen KR, Kahkonen MP, Torronen AR, Heinonen IM (2005) Catechins and procyanidins in berries of vaccinium species and their antioxidant activity. J Agric Food Chem 53:8485–8491CrossRef
26.
Zurück zum Zitat Mazur WM, Uehara M, Wahala K, Adlercreutz H (2000) Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects. Br J Nutr 83:381–387 Mazur WM, Uehara M, Wahala K, Adlercreutz H (2000) Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects. Br J Nutr 83:381–387
27.
Zurück zum Zitat Scalbert A, Manach C, Morand C, Remesy C, Jimenez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287–306CrossRef Scalbert A, Manach C, Morand C, Remesy C, Jimenez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287–306CrossRef
28.
Zurück zum Zitat Manach C, Mazur A, Scalbert A (2005) Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16:77–84CrossRef Manach C, Mazur A, Scalbert A (2005) Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16:77–84CrossRef
29.
Zurück zum Zitat Tonstad S, Klemsdal TO, Landaas S, Hoieggen A (2006) No effect of increased water intake on blood viscosity and cardiovascular risk factors. Br J Nutr 96:993–996CrossRef Tonstad S, Klemsdal TO, Landaas S, Hoieggen A (2006) No effect of increased water intake on blood viscosity and cardiovascular risk factors. Br J Nutr 96:993–996CrossRef
30.
Zurück zum Zitat Karlsen A, Retterstol L, Laake P, Paur I, Kjolsrud-Bohn S, Sandvik L, Blomhoff R (2007) Anthocyanins Inhibit Nuclear Factor-{kappa}B Activation in Monocytes and Reduce Plasma Concentrations of Pro-Inflammatory Mediators in Healthy Adults. J Nutr 137:1951–1954 Karlsen A, Retterstol L, Laake P, Paur I, Kjolsrud-Bohn S, Sandvik L, Blomhoff R (2007) Anthocyanins Inhibit Nuclear Factor-{kappa}B Activation in Monocytes and Reduce Plasma Concentrations of Pro-Inflammatory Mediators in Healthy Adults. J Nutr 137:1951–1954
31.
Zurück zum Zitat Benzie IF, Strain JJ (1999) Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Meth Enzymol 299:15–27CrossRef Benzie IF, Strain JJ (1999) Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Meth Enzymol 299:15–27CrossRef
32.
Zurück zum Zitat Serafini M, Bugianesi R, Salucci M, Azzini E, Raguzzini A, Maiani G (2002) Effect of acute ingestion of fresh and stored lettuce (Lactuca sativa) on plasma total antioxidant capacity and antioxidant levels in human subjects. Br J Nutr 88:615–623CrossRef Serafini M, Bugianesi R, Salucci M, Azzini E, Raguzzini A, Maiani G (2002) Effect of acute ingestion of fresh and stored lettuce (Lactuca sativa) on plasma total antioxidant capacity and antioxidant levels in human subjects. Br J Nutr 88:615–623CrossRef
33.
Zurück zum Zitat Davalos A, Gomez-Cordoves C, Bartolome B (2004) Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay. J Agric Food Chem 52:48–54CrossRef Davalos A, Gomez-Cordoves C, Bartolome B (2004) Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay. J Agric Food Chem 52:48–54CrossRef
34.
Zurück zum Zitat Karlsen A, Blomhoff R, Gundersen TE (2005) High-throughput analysis of vitamin C in human plasma with the use of HPLC with monolithic column and UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci 824:132–138CrossRef Karlsen A, Blomhoff R, Gundersen TE (2005) High-throughput analysis of vitamin C in human plasma with the use of HPLC with monolithic column and UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci 824:132–138CrossRef
35.
Zurück zum Zitat Karlsen A, Blomhoff R, Gundersen TE (2007) Stability of whole blood and plasma ascorbic acid. Eur J Clin Nutr 61:1233–1236CrossRef Karlsen A, Blomhoff R, Gundersen TE (2007) Stability of whole blood and plasma ascorbic acid. Eur J Clin Nutr 61:1233–1236CrossRef
36.
Zurück zum Zitat Sakhi AK, Russnes KM, Smeland S, Blomhoff R, Gundersen TE (2006) Simultaneous quantification of reduced and oxidized glutathione in plasma using a two-dimensional chromatographic system with parallel porous graphitized carbon columns coupled with fluorescence and coulometric electrochemical detection. J Chromatogr A 1104:179–189CrossRef Sakhi AK, Russnes KM, Smeland S, Blomhoff R, Gundersen TE (2006) Simultaneous quantification of reduced and oxidized glutathione in plasma using a two-dimensional chromatographic system with parallel porous graphitized carbon columns coupled with fluorescence and coulometric electrochemical detection. J Chromatogr A 1104:179–189CrossRef
37.
Zurück zum Zitat Bohn SK, Smeland S, Sakhi AK, Thoresen M, Russnes KM, Tausjo J, Svilaas A, Svilaas T, Blomhoff R (2006) Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett 238:240–247CrossRef Bohn SK, Smeland S, Sakhi AK, Thoresen M, Russnes KM, Tausjo J, Svilaas A, Svilaas T, Blomhoff R (2006) Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett 238:240–247CrossRef
38.
Zurück zum Zitat Richheimer S, Kent M, Bernart M (1994) Reversed-phase high-performance liquid chromatographic method using a pentafluorophenyl bonded phase for analysis of tocopherols. J Chrom A 677:75–80CrossRef Richheimer S, Kent M, Bernart M (1994) Reversed-phase high-performance liquid chromatographic method using a pentafluorophenyl bonded phase for analysis of tocopherols. J Chrom A 677:75–80CrossRef
39.
Zurück zum Zitat Erlund I, Alfthan G, Siren H, Ariniemi K, Aro A (1999) Validated method for the quantitation of quercetin from human plasma using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 727:179–189CrossRef Erlund I, Alfthan G, Siren H, Ariniemi K, Aro A (1999) Validated method for the quantitation of quercetin from human plasma using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 727:179–189CrossRef
40.
Zurück zum Zitat Kilkkinen A, Erlund I, Virtanen MJ, Alfthan G, Ariniemi K, Virtamo J (2006) Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers. Am J Epidemiol 163:687–693CrossRef Kilkkinen A, Erlund I, Virtanen MJ, Alfthan G, Ariniemi K, Virtamo J (2006) Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers. Am J Epidemiol 163:687–693CrossRef
41.
Zurück zum Zitat Carlsen H, Moskaug JO, Fromm SH, Blomhoff R (2002) In vivo imaging of NF-kappa B activity. J Immunol 168:1441–1446 Carlsen H, Moskaug JO, Fromm SH, Blomhoff R (2002) In vivo imaging of NF-kappa B activity. J Immunol 168:1441–1446
42.
Zurück zum Zitat Bakhtiarova A, Taslimi P, Elliman SJ, Kosinski PA, Hubbard B, Kavana M, Kemp DM (2006) Resveratrol inhibits firefly luciferase. Biochem Biophys Res Commun 351:481–484CrossRef Bakhtiarova A, Taslimi P, Elliman SJ, Kosinski PA, Hubbard B, Kavana M, Kemp DM (2006) Resveratrol inhibits firefly luciferase. Biochem Biophys Res Commun 351:481–484CrossRef
43.
Zurück zum Zitat Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA (1998) Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci USA 95:2452–2457CrossRef Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA (1998) Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci USA 95:2452–2457CrossRef
44.
Zurück zum Zitat Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10:2327–2334 Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10:2327–2334
45.
Zurück zum Zitat Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV (1990) Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171:35–47CrossRef Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV (1990) Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171:35–47CrossRef
46.
Zurück zum Zitat Bunting K, Rao S, Hardy K, Woltring D, Denyer GS, Wang J, Gerondakis S, Shannon MF (2007) Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel. J Immunol 178:7097–7109 Bunting K, Rao S, Hardy K, Woltring D, Denyer GS, Wang J, Gerondakis S, Shannon MF (2007) Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel. J Immunol 178:7097–7109
47.
Zurück zum Zitat Moriuchi H, Moriuchi M, Fauci AS (1997) Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 158:3483–3491 Moriuchi H, Moriuchi M, Fauci AS (1997) Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 158:3483–3491
48.
Zurück zum Zitat Kumar A, Takada Y, Boriek AM, Aggarwal BB (2004) Nuclear factor-kappaB: its role in health and disease. J Mol Med 82:434–448CrossRef Kumar A, Takada Y, Boriek AM, Aggarwal BB (2004) Nuclear factor-kappaB: its role in health and disease. J Mol Med 82:434–448CrossRef
49.
Zurück zum Zitat Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE (2006) Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 136:981–986 Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE (2006) Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 136:981–986
50.
Zurück zum Zitat Ridker PM (2005) C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J 32:384–386 Ridker PM (2005) C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J 32:384–386
51.
Zurück zum Zitat Waehre T, Halvorsen B, Damas JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Froland SS, Aukrust P (2002) Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 32:803–810CrossRef Waehre T, Halvorsen B, Damas JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Froland SS, Aukrust P (2002) Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 32:803–810CrossRef
52.
Zurück zum Zitat Terkeltaub RA (1999) IL-10: An “immunologic scalpel” for atherosclerosis? Arterioscler Thromb Vasc Biol 19:2823–2825 Terkeltaub RA (1999) IL-10: An “immunologic scalpel” for atherosclerosis? Arterioscler Thromb Vasc Biol 19:2823–2825
53.
Zurück zum Zitat Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17–e24 Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17–e24
54.
Zurück zum Zitat Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I: review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242S Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I: review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242S
55.
Zurück zum Zitat Paur I, Austenaa LM, Blomhoff R (2008) Extracts of dietary plants are efficient modulators of nuclear factor kappa B. Food Chem Toxicol 46:1288–1297CrossRef Paur I, Austenaa LM, Blomhoff R (2008) Extracts of dietary plants are efficient modulators of nuclear factor kappa B. Food Chem Toxicol 46:1288–1297CrossRef
Metadaten
Titel
Bilberry juice modulates plasma concentration of NF-κB related inflammatory markers in subjects at increased risk of CVD
verfasst von
Anette Karlsen
Ingvild Paur
Siv K. Bøhn
Amrit K. Sakhi
Grethe I. Borge
Mauro Serafini
Iris Erlund
Petter Laake
Serena Tonstad
Rune Blomhoff
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 6/2010
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-010-0092-0

Weitere Artikel der Ausgabe 6/2010

European Journal of Nutrition 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.